- Avid Bioservices (NASDAQ:CDMO) is scheduled to announce Q4 earnings results on Tuesday, July 2nd, after market close.
- The consensus EPS Estimate is -$0.01 and the consensus Revenue Estimate is $42.14M (+5.9% Y/Y).
- Over the last 2 years, CDMO has beaten EPS estimates 25% of the time and has beaten revenue estimates 75% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 2 downward. Revenue estimates have seen 1 upward revision and 3 downward.
2024-07-01